Patents
Patents for C07K 1 - General processes for the preparation of peptides (51,718)
11/1995
11/28/1995US5470703 Method for peptide C-terminal fragment sequence analysis and apparatus for collecting peptide fragment
11/28/1995CA1337671C Process for recovering purified, oxidized, renatured recombinant interleukin-2 from microorganisms
11/28/1995CA1337641C Recombinant dna product and method
11/28/1995CA1337640C Recombinant dna product and method
11/23/1995WO1995031727A1 Sterile and pyrogen-free columns coupled to protein for binding and removal of substances from blood
11/23/1995WO1995031479A1 Methods and compositions for the dry powder formulation of interferons
11/23/1995WO1995031429A1 Photocleavable agents and conjugates for the detection and isolation of biomolecules
11/23/1995WO1995031279A1 Chromatography adsorbents utilizing mercapto heterocyclic ligands
11/23/1995WO1995031210A1 Peptides and compounds that bind selectins including endothelium leukocyte adhesion molecule 1 (elam-1)
11/23/1995CA2190502A1 Methods and compositions for the dry powder formulation of interferons
11/22/1995EP0683173A1 Cyclic adhesion inhibitors
11/22/1995CN1112125A Acyloxyhexanoic acid derivatives
11/22/1995CN1112019A Novel process for the preparation of cetrorelix lyophilisate
11/22/1995CN1111946A Protein isolate having an increased level of lsoflavone compounds, and process for producing the same
11/21/1995US5468847 Method of isolating and purifying a biomacromolecule
11/21/1995US5468844 Process for the membrane-filtering of protein solutions
11/21/1995US5468843 Acetic anhydride activation for C-terminal protein sequencing
11/21/1995US5468731 Peptide compounds, a process for preparation thereof and pharmaceutical composition comprising the same
11/21/1995US5468480 Pharmaceutical composition of purified chymopapain
11/16/1995WO1995030694A1 New opioid peptide analogs with mixed mu agonist/delta antagonist properties
11/16/1995WO1995030691A1 New peptide active substance and production thereof
11/16/1995WO1995030689A1 Improved method for the preparation of an aspartame-derived compound useful as a sweetener
11/16/1995WO1995030688A1 N-[N-(3,3-DIMETHYLBUTYL)-L-α-ASPARTYL]-L-HEXAHYDROPHENYLALANINE 1-METHYL ESTER USEFUL AS A SWEETENING AGENT AND METHOD OF PREPARATION
11/16/1995WO1995030686A1 Production of biologically active recombinant neurotrophic protein
11/16/1995WO1995022258A3 Isolation of lactoferrin from milk
11/16/1995CA2189558A1 N-¬n-(3,3-dimethylbutyl)-l-.alpha.-aspartyl|-l-hexahydrophenylalanine 1-methyl ester useful as a sweetening agent and method of preparation
11/16/1995CA2188670A1 New opioid peptide analogs with mixed mu agonist/delta antagonist properties
11/15/1995EP0682257A1 Methods of detecting collagen degradation in vivo
11/15/1995EP0682256A1 Methods of detecting collagen degradation in vivo
11/15/1995EP0682110A1 Recombinant DNA encoding PDGF A-chain polypeptides
11/15/1995EP0682040A1 Humanized immunoglobulins and their production and use
11/15/1995EP0527977B1 Nematode vaccine
11/15/1995EP0480949B1 Production of virus and purification of viral envelope proteins for vaccine use
11/15/1995EP0420913B1 Heterofunctional cellular immunological reagents, vaccines containing same and methods for the use of same
11/15/1995CN1030255C Ring groth hormone releasing factor (GRF), analogue and its process
11/14/1995US5466608 Process and apparatus for heterogeneous phase synthesis of macromolecules such as peptides, polynucloetides or oligosaccharides
11/09/1995WO1995030016A1 Methods for peptide synthesis and purification
11/09/1995WO1995030009A2 Identification, production and use of saponin glyclosyl hydrolases
11/09/1995WO1995029933A1 Modified milk growth factor
11/09/1995WO1995029694A1 Collagen hydrolysis accelerator
11/09/1995DE4415997A1 Neuer peptidischer Wirkstoff und dessen Herstellung New peptidic drug and its preparation
11/09/1995CA2165413A1 Methods for peptide synthesis and purification
11/08/1995EP0680990A1 Collagen-synthetic polymer matrices prepared using a multiple step reaction
11/08/1995EP0680972A1 Trifluoromethylketone peptide derivatives, process for their preparation and pharmaceutical compositions comprising them
11/08/1995CN1111283A After-treatment method for producing thuricide suspension
11/08/1995CN1111237A Preparation of amides and peptides
11/07/1995US5464939 Highly purified protein, production and use thereof
11/07/1995US5464934 Metal chelates as spacer compounds in biologically active peptides
11/07/1995US5464822 Polypeptides and polypeptide analogues
11/07/1995US5464759 Sequential oligonucleotide syntheses using immunoaffinity techniques
11/07/1995US5464756 Processes and compositions for the isolation of human relaxin
11/07/1995CA1337518C Monoclonal antibodies against tnf-–, hybridomas producing them and method for the purification of tnf-–
11/06/1995CA2148650A1 Peptides derived from trifluoromethylketones; process for preparing the same and pharmaceutical compositions containing them
11/03/1995CA2143923A1 Collagen-synthetic polymer matrices prepared using a multiple step reaction
11/02/1995WO1995028838A1 Modified amino acids for drug delivery
11/02/1995EP0679718A2 Process for producing alpha-interferon
11/02/1995EP0679717A2 Soluble interferon -receptor, its preparation and use
11/02/1995EP0679659A1 Cathepsin-l-specific inhibitor polypeptide
11/02/1995EP0679091A1 Chemotactic factors for human spermatozoa and their use in human assisted fertilization
11/02/1995EP0562047A4 Sequencing by hybridization of a target nucleic acid to a matrix of defined oligonucleotides
11/02/1995CA2188467A1 Modified amino acids for drug delivery
11/01/1995CN1111058A Inhibitor of collagen-stimulated platelet aggregation
10/1995
10/31/1995US5463564 System and method of automatically generating chemical compounds with desired properties
10/31/1995US5463029 Adsorbing, eluting on cationic exchange resin, followed by same on anionic exchange resin
10/31/1995US5463025 Protein having human plasmin inhibiting activity
10/31/1995US5462925 Transforming growth factor β2,3
10/31/1995US5462748 For stepwise addition of biopolymer subunits to growing biopolymer chain on a solid phase support
10/29/1995CA2147925A1 Pseudopeptides derived from neurokinins; process for preparing the same and pharmaceutical compositions containing them
10/26/1995WO1995028640A1 Complex combinatorial chemical libraries encoded with tags
10/26/1995WO1995028415A1 Method of protein and peptide cleavage
10/26/1995WO1995028172A1 Human bone stimulating factor
10/26/1995CA2188172A1 Human bone stimulating factor
10/26/1995CA2187792A1 Complex combinatorial chemical libraries encoded with tags
10/25/1995EP0678522A1 Insulin analogs
10/25/1995EP0678102A1 Process for the purification and refolding of human respiratory syncytial virus fg glycoprotein
10/25/1995EP0678099A1 New peptides
10/25/1995EP0678098A1 Pyrrolidine and thiazolidine derivatives, their preparation and drugs containing same
10/25/1995EP0506818B1 Method of covalently bonding proteins to hydrophilic surfaces
10/25/1995EP0434836B1 Method for purifying tenascin
10/25/1995EP0294392B1 Diagnostic and therapeutic antibody conjugates
10/25/1995CN1110681A Protein and polypeptide mercapto-polyglycol (PEG) reagent
10/24/1995US5461035 Short peptides with insulin activity
10/24/1995US5461029 Method of treating herpes viral infections using HBNF and MK proteins
10/24/1995US5460978 Protein active in humoral hypercalcemia of malignancy-PthrP
10/24/1995US5460960 Isolating antibodies produced by a hapten similar to both the reactant and catalyst; modifying these antibodies by binding a converting hapten for the reactant/actual catalyst complex
10/24/1995US5460956 Method for preparing interferon alpha-2 crystals
10/24/1995US5460786 Cleaving peptied-solid support bond and removing side chain protecting groups
10/24/1995US5460785 Direct labeling of antibodies and other protein with metal ions
10/24/1995CA1337433C Protecting groups for asparagine and glutamine in peptide synthesis
10/24/1995CA1337407C Dimeric peptides having a stimulatory effect on haemopoiesis and a process for their preparation
10/19/1995WO1995027901A1 Class i peptide binding motifs
10/19/1995WO1995027732A2 Circularly permuted ligands and circularly permuted chimeric molecules
10/19/1995WO1995027727A2 Process for peptide segment condensation
10/19/1995CA2186605A1 Process for peptide segment condensation
10/18/1995EP0677531A1 Derivates of boronic peptides, preparation and use thereof in therapy
10/18/1995EP0677107A1 Clotting inhibitor made from protostomia saliva.
10/18/1995EP0677058A1 Support and method for immobilizing polypeptides
10/18/1995EP0677057A1 Biopolymer synthesis utilizing surface activated, organic polymers
10/18/1995EP0676964A1 Nitrosylation of protein sh groups and amino acid residues as a therapeutic modality
10/18/1995EP0629144B1 Device for simultaneously or successively carrying out chemical reactions